Formulation and Optimization of Captopril Sublingual Tablet Using D-Optimal DesignSublingual Tablet Using D-Optimal Design

Authors

Noushin Bolourtchian1, 2,*, Naghmeh Hadidi1, Seyed Mohsen Foroutan1, 2, Bijan Shafaghi1
1School of Pharmacy, Shaheed Beheshti University (M.C.), P. O. Box: 14155-6153, Tehran, Iran
2Pharmaceutical Sciences Research Center, Shaheed Beheshti University (M.C.), Tehran, Iran
*Corresponding Author: School of Pharmacy, Shaheed Beheshti University (M.C.), P. O. Box: 14155-6153, Tehran, Iran. Email:[email protected]

IJ Pharmaceutical Research:Vol. 7, issue 4; 259-267
Published online:Nov 20, 2010
Article type:Research Article
Received:May 01, 2008
Accepted:Jun 01, 2008
How to Cite:Bolourtchian N, Hadidi N, Foroutan SM, Shafaghi B. Formulation and Optimization of Captopril Sublingual Tablet Using D-Optimal DesignSublingual Tablet Using D-Optimal Design. Iran J Pharm Res. 2022;7(4):e128600. doi: https://doi.org/10.22037/ijpr.2010.774

Abstract

The objective of the current study was to develop and optimize a sublingual tablet formulation of captopril which is an effective drug in the treatment of hypertension. Captopril containing tablets were prepared by direct compression method using different ingredients such as polyvinyl pyrrolidone, starch 1500, sodium starch glycolate and lactose (independent variables) and magnesium stearate, talc and aspartame (fixed components). Tablets were evaluated for the physical properties including hardness, disintegration time and friability which were considered as responses in a D-optimal experimental plan. Results were statistically examined using special cubic model and polynomial mathematical equations and found to be statistically significant (p<0.05) for disintegration time and friability data. Meanwhile linear model was best fitted with hardness data. The obtained results were used to generate optimized overlay plot. The physical data from the numerical optimization were verified and found to be very close to those predicted from the regression analysis. Additional experiments including drug content, in vitro drug dissolution rate and accelerated stability studies were also performed on the optimum formulation. All results were in accordance with the requirements of a sublingual tablet.

Copyright

© 2022, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

8
Mar
2014

Formulation and Evaluation of Orally Disintegrating Tablets of Captopril Using Natural Super Disintegrants

Mohammad Ali Shahtalebi,
Majid Tabbakhian,
Navid Sarbolookzadeh Harandi

Shahtalebi MA, Tabbakhian M, Sarbolookzadeh Harandi N. Formulation and Evaluation of Orally Disintegrating Tablets of Captopril Using Natural Super Disintegrants. J Rep Pharm Sci. 2014;3(1):e147727. doi:

31
Oct
2018

Formulation Optimization and Assessment of Dexamethasone Orally Disintegrating Tablets Using Box-Behnken Design

Hadis Soroush,
Fatemeh Ghorbani-Bidkorbeh,
Seyed Alireza Mortazavi,
Ali Mehramizi

Soroush H, Ghorbani-Bidkorbeh F, Mortazavi SA, Mehramizi A. Formulation Optimization and Assessment of Dexamethasone Orally Disintegrating Tablets Using Box-Behnken Design. Iran J Pharm Res. 2018;17(4):e124870. doi: https://doi.org/10.22037/ijpr.2018.2318

29
Nov
2016

Design, Formulation and Evaluation of Its Physiochemical Properties of Acetaminophen, Ibuprofen and Caffeine as Effervescent Tablet

Abolfazl Aslani,
Ali Daliri

Aslani A, Daliri A. Design, Formulation and Evaluation of Its Physiochemical Properties of Acetaminophen, Ibuprofen and Caffeine as Effervescent Tablet. J Rep Pharm Sci. 2016;5(2):e147652. doi:

11
Aug
2013

Design, Formulation and Physicochemical Evaluation of Acetaminophen Effervescent Tablets

Abolfazl Aslani,
Parisa Eatesam

Aslani A, Eatesam P. Design, Formulation and Physicochemical Evaluation of Acetaminophen Effervescent Tablets. J Rep Pharm Sci. 2013;2(2):e147747. doi:

31
Jan
2014

Formulation and In-vitro Characterization of Sustained Release Matrix Type Ocular Timolol Maleate Mini-Tablet

Seyed Alireza Mortazavi,
Zahra Jafariazar,
Yasaman Ghadjahani,
Hoda Mahmoodi,
Farzaneh Mehtarpour

Mortazavi SA, Jafariazar Z, Ghadjahani Y, Mahmoodi H, Mehtarpour F. Formulation and In-vitro Characterization of Sustained Release Matrix Type Ocular Timolol Maleate Mini-Tablet. Iran J Pharm Res. 2014;13(1):e125456. doi: https://doi.org/10.22037/ijpr.2014.1435

More by these authors

Noushin BolourtchianPubMedScholar
Naghmeh HadidiPubMedScholar
Seyed Mohsen ForoutanPubMedScholar
Bijan ShafaghiPubMedScholar
Share
Cited by
Metrics